Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 232 for “"RADIOPHARMACEUTICAL"”.

  1. New chelators for radiopharmaceutical chemistry

    This thesis presents studies on a new family of oxine (8-hydroxyquinoline) based acyclic chelators for application to radiometals (e.g., ⁶⁴Cu, ⁶⁷/⁶⁸Ga, ¹¹¹In) in nuclear medicine. Picolinic acid-based chelators (“pa” family) are reported as excellent radiometal chelators by our group’s previous …

    ubc Repository record for New chelators for radiopharmaceutical chemistry (opens in a new tab) Download PDF for New chelators for radiopharmaceutical chemistry (opens in a new tab)

  2. New chelating systems for radiopharmaceutical diagnosis

    … radioisotopes having potential application in radiopharmaceutical imaging systems. The first section reviews the currently available methods of radioimaging with particular emphasis on the limitations of the pharmaceutical reagents currently used for this important medical diagnostic tool. …

    soton Download PDF for New chelating systems for radiopharmaceutical diagnosis (opens in a new tab)

  3. Towards Radiopharmaceutical Synthesis Using Fluorous Chemistry

    … traditional radiolabelling approaches used in radiopharmaceutical synthesis often generate multiple products, which require exhaustive HPLC purification prior to use.2 Chromatographic purification reduces radiochemical yields, increases exposure, and can, in certain cases, preclude the use of …

    mcmaster Repository record for Towards Radiopharmaceutical Synthesis Using Fluorous Chemistry (opens in a new tab)

  4. Nonmacrocyclic ligand development for inorganic radiopharmaceutical chemistry

    … or therapy. Designing new compounds for radiopharmaceuticals usually considers four components including a radionuclide, a bifunctional chelator, a targeting vector, and a linker. Taking the small, bidentate molecule 8-hydroxyquinoline from its historic use in nuclear medicine as …

    ubc Repository record for Nonmacrocyclic ligand development for inorganic radiopharmaceutical chemistry (opens in a new tab) Download PDF for Nonmacrocyclic ligand development for inorganic radiopharmaceutical chemistry (opens in a new tab)

  5. Tools for the Advancement of Radiopharmaceutical Therapy

    Radiopharmaceutical therapy is used to treat cancers and other diseases with radiolabeled pharmaceuticals. The treatment targets specific cells, and the emitted ionizing radiation cause cytotoxic damage. Dosimetry is performed to estimate the absorbed dose from the energy deposited in the body. …

    lund Repository record for Tools for the Advancement of Radiopharmaceutical Therapy (opens in a new tab) Download PDF for Tools for the Advancement of Radiopharmaceutical Therapy (opens in a new tab)

  6. Identification of novel radiopharmaceutical DNA aptamers against MUC1

    the-open-u

  7. Comparison of selected radiopharmaceutical chromatographic quality control procedures

    The purpose of this study was to compare the accuracy and reproducibility of two commercially available chromatography kits with Instant Thin Layer Chromatography-Silica Gel (ITLC-SG) and Whatman Chromatography Paper. The two commercial kits evaluated were the- MAC Klt- produced-General …

    u-pacific Repository record for Comparison of selected radiopharmaceutical chromatographic quality control procedures (opens in a new tab)

  8. Investigating the bifunctional chelate approach for radiopharmaceutical development

    … THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Radiopharmaceuticals are drugs that contain a radioactive atom for the purpose of imaging or therapy of disease. The type of emission determines the applicability for each drug. For instance, alpha and beta particles are used for treatment of …

    missouri Repository record for Investigating the bifunctional chelate approach for radiopharmaceutical development (opens in a new tab)

  9. Development of a ¹⁶¹Tb-based radiopharmaceutical for melanoma

    … of modalities for treatment. Targeted radiopharmaceuticals represent one of these modalities that hold the potential for diagnosing and treating diseases such as cancer. This work presents the preparation and characterization of two ¹⁶¹Tb radiolabeled radiopharmaceuticals which are …

    missouri Repository record for Development of a ¹⁶¹Tb-based radiopharmaceutical for melanoma (opens in a new tab) Embargoed until 2026-12-01

  10. Growing Need for a Standardized Response to Radiopharmaceutical Extravasations

    … site, rather than into the bloodstream. With radiopharmaceuticals, extravasations can result in potentially large radiation doses to skin and tissue. The current rate of extravasations in clinical settings is estimated to be between 3-23%. In the interest of patient safety, a clearer …

    uab Repository record for Growing Need for a Standardized Response to Radiopharmaceutical Extravasations (opens in a new tab)

  11. Challenges Of Lutetium-177 Metastable Concentration In Radiopharmaceutical Waste

    Lutetium-177 (Lu-177) is an upcoming radiopharmaceutical with commercial use recently approved for cancer treatment by the Federal Drug Administration (FDA). During production, a contaminate, Lutetium-177 metastable (Lu-177m), can also be produced. The concentration of Lu-177m will vary greatly …

    uab Repository record for Challenges Of Lutetium-177 Metastable Concentration In Radiopharmaceutical Waste (opens in a new tab)

  12. Approaches to functionalised amine-based ligands for radiopharmaceutical delivery systems

    … ligands intended for use as novel diagnostic radiopharmaceutical agents through technetium complexation and attachment to bioactive targeting groups. The literature concerning radiopharmaceutical imaging agents is reviewed. The main body of the thesis concerns a study focused on two ligand …

    soton Download PDF for Approaches to functionalised amine-based ligands for radiopharmaceutical delivery systems (opens in a new tab)

  13. GRPR-/PSMA- dual targeted radiopharmaceutical heterodimers : theranostics in prostate cancer

    … diagnostic and therapeutic tools. Heterobivalent radiopharmaceuticals, which target single- or multi-targetable receptors simultaneously, offer a promising strategy to enhance tumor specificity and imaging contrast. This dissertation presents the development and preclinical evaluation of …

    missouri Repository record for GRPR-/PSMA- dual targeted radiopharmaceutical heterodimers : theranostics in prostate cancer (opens in a new tab)

  14. Technetium and rhenium (I and V) complexes for radiopharmaceutical applications

    … and relatively affordable option. Two Tc-99m radiopharmaceuticals were created that seek to target somatostatin receptors (SSTRs), which are commonly overexpressed on neuroendocrine tumor tissues. Two different histidine-derived BFCAs were used to chelate a technetium-99m tricarbonyl core …

    missouri Repository record for Technetium and rhenium (I and V) complexes for radiopharmaceutical applications (opens in a new tab)

  15. Neural-Network-Based Detection of Radiopharmaceutical Extravasation In PET/CT Data

    <p>The immediate identification of PET/CT radiopharmaceutical extravasation can eliminate many adverse effects such as misdiagnosis and improper therapy. Radiopharmaceutical extravasation is the leakage of an injected radiotracer from the patient’s intended vein into surrounding tissues. The …

    ut-knoxville Repository record for Neural-Network-Based Detection of Radiopharmaceutical Extravasation In PET/CT Data (opens in a new tab)

  16. Use of physiologically based radiopharmacokinetic (PBRPK) models to simulate radiopharmaceutical therapies

    … based pharmacokinetic (PBPK) models to study radiopharmaceutical kinetics in the body. To handle the complexity of PBPK models (over 100 differential equations), a scalable modeling notation called the "reaction graph" is introduced. Implemented in Matlab's Simbiology module and shared in the …

    ubc Repository record for Use of physiologically based radiopharmacokinetic (PBRPK) models to simulate radiopharmaceutical therapies (opens in a new tab) Download PDF for Use of physiologically based radiopharmacokinetic (PBRPK) models to simulate radiopharmaceutical therapies (opens in a new tab)

  17. 3D-PRINTED MICROFLUIDIC CAPILLARIC CIRCUITS FOR THE AUTOMATION OF RADIOPHARMACEUTICAL SYNTHESIS

    … stem cells in vivo, but the radiopharmaceuticals required for PET-based tracking, such as [89Zr]Zr-SCN-Bn-DFO, are currently synthesized and handled manually. This manual process exposes laboratory personnel to prolonged, close-proximity radiation during pipetting, mixing, and …

    maryland Repository record for 3D-PRINTED MICROFLUIDIC CAPILLARIC CIRCUITS FOR THE AUTOMATION OF RADIOPHARMACEUTICAL SYNTHESIS (opens in a new tab)

  18. Fabrication of a novel radiopharmaceutical: lutetium-177 loaded MCM-41mesoporous silica

    [ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Targeted therapy of cancer, by binding the radionuclide with a carrier agent, provides more accurate delivery to focal tumor cell with low uptake in normal organs. In this paper, a new radio-loaded nanoparticle has been …

    missouri Repository record for Fabrication of a novel radiopharmaceutical: lutetium-177 loaded MCM-41mesoporous silica (opens in a new tab)

Page 1 of 12